Annual report pursuant to Section 13 and 15(d)

Common Stock and Stock-Based Incentive Compensation Plans - Weighted Average Valuation Assumptions for Stock Options (Details)

v3.22.4
Common Stock and Stock-Based Incentive Compensation Plans - Weighted Average Valuation Assumptions for Stock Options (Details) - Stock Options
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Outstanding Number of Shares  
Balance, beginning of period (in shares) | shares 5
Granted (in shares) | shares 1
Exercised (in shares) | shares (2)
Balance, end of period (in shares) | shares 4
Exercisable, end of period (in shares) | shares 3
Weighted- Average Exercise Price  
Balance, beginning of period (USD per share) | $ / shares $ 23.98
Granted (USD per share) | $ / shares 95.54
Exercised (USD per share) | $ / shares 4.27
Balance, end of period (USD per share) | $ / shares 42.35
Exercisable, end of period (USD per share) | $ / shares $ 25.67
Aggregate Intrinsic Value  
Balance | $ $ 130
Exercisable December 31, 2022 | $ $ 130
Weighted-Average Remaining Contractual Life (in years)  
Balance 3 years 2 months 1 day
Exercisable December 31, 2022 2 years 3 months 7 days